A Prognostic Gene Signature for Hepatocellular Carcinoma

被引:10
作者
Chen, Rong [1 ]
Zhao, Meng [2 ]
An, Yanli [3 ,4 ]
Liu, Dongfang [3 ]
Tang, Qiusha [3 ]
Teng, Gaojun [4 ]
机构
[1] Zhongda Hosp, Dept Oncol, Nanjing, Peoples R China
[2] Zhengzhou Univ, Sch Basic Med, Zhengzhou, Peoples R China
[3] Southeast Univ, Med Sch, Nanjing, Peoples R China
[4] Southeast Univ, Dept Radiol, Med Sch, Nanjing, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
hepatocellular carcinoma; bioinformatics analysis; immune-related prognostic genes; immune cells; gene signature; CELL CARCINOMA; RECEPTOR CCR3; EXPRESSION; MUTATIONS; TP53; S100A8; SURVIVAL; P53; IDENTIFICATION; SURVEILLANCE;
D O I
10.3389/fonc.2022.841530
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma is the third most common cause of cancer-related deaths in China and immune-based therapy can improve patient outcomes. In this study, we investigated the relationship between immunity-associated genes and hepatocellular carcinoma from the prognostic perspective. The data downloaded from The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA-LIHC) and the Gene Expression Omnibus (GEO) was screened for gene mutation frequency using the maftools package. Immunity-associated eight-gene signature with strong prognostic ability was constructed and proved as an independent predictor of the patient outcome in LIHC. Seven genes in the immune-related eight-gene signature were strongly associated with the infiltration of M0 macrophages, resting mast cells, and regulatory T cells. Our research may provide clinicians with a quantitative method to predict the prognosis of patients with liver cancer, which can assist in the selection of the optimal treatment plan.
引用
收藏
页数:11
相关论文
共 79 条
[41]  
Lang Bin, 2016, Med Sci Monit, V22, P1953
[42]   Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells [J].
Lim, S. Y. ;
Yuzhalin, A. E. ;
Gordon-Weeks, A. N. ;
Muschel, R. J. .
ONCOGENE, 2016, 35 (44) :5735-5745
[43]   Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: Evidence from a systematic review and meta-analysis [J].
Liu, Jiangbo ;
Ma, Qingyong ;
Zhang, Min ;
Wang, Xinshuai ;
Zhang, Dong ;
Li, Wei ;
Wang, Fengfei ;
Wu, Erxi .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (15) :2328-2338
[44]   Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma [J].
Long, Junyu ;
Wang, Anqiang ;
Bai, Yi ;
Lin, Jianzhen ;
Yang, Xu ;
Wang, Dongxu ;
Yang, Xiaobo ;
Jiang, Yan ;
Zhao, Haitao .
EBIOMEDICINE, 2019, 42 :363-374
[45]   Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment [J].
Lu, Li-Chun ;
Lee, Yi-Hsuan ;
Chang, Chun-Jung ;
Shun, Chia-Tung ;
Fang, Chih-Yeu ;
Shao, Yu-Yun ;
Liu, Tsung-Hao ;
Cheng, Ann-Lii ;
Hsu, Chih-Hung .
LIVER CANCER, 2019, 8 (02) :110-120
[46]   Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma [J].
Matsuda, Shinichi ;
Mafune, Aki ;
Kohda, Nagisa ;
Hama, Takanori ;
Urashima, Mitsuyoshi .
PLOS ONE, 2020, 15 (04)
[47]   Maftools: efficient and comprehensive analysis of somatic variants in cancer [J].
Mayakonda, Anand ;
Lin, De-Chen ;
Assenov, Yassen ;
Plass, Christoph ;
Koeffler, H. Phillip .
GENOME RESEARCH, 2018, 28 (11) :1747-1756
[48]   BRCA1 Is a Novel Prognostic Indicator and Associates with Immune Cell Infiltration in Hepatocellular Carcinoma [J].
Mei, Jie ;
Wang, Runjie ;
Xia, Dandan ;
Yang, Xuejing ;
Zhou, Weijian ;
Wang, Huiyu ;
Liu, Chaoying .
DNA AND CELL BIOLOGY, 2020, 39 (10) :1838-1849
[49]   Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation [J].
Na, Bing ;
Yu, Xin ;
Withers, Tracy ;
Gilleran, John ;
Yao, Ming ;
Foo, Tzeh Keong ;
Chen, Chunxia ;
Moore, Dirk ;
Linz, Yong ;
Kimball, S. David ;
Xia, Bing ;
Ganesan, Shridar ;
Carpizo, Darren R. .
NPJ BREAST CANCER, 2019, 5 (1)
[50]  
Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]